|
⚲
|
| Keyboard |
| Manning Paul B
✚
|
|
|---|---|
| CIK # | 0001494695 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001494695] | |
| 4 | [0001494695] | |
| 5 | [0001494695] | |
| SC 13D | [0001494695] | |
| SC 13G | [0001494695] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Candel Therapeutics Inc CADL
Common Stock
|
2026-02-23 | Buy | 550,458 | $5.45 | 2,999,996 |
|
Liquidia Corp LQDA
Common Stock
|
2026-02-11 | Other | 55,116 | $42.63 | 2,349,595 |
|
Liquidia Corp LQDA
Common Stock
|
2026-02-11 | Other | 55,116 | $42.63 | 2,349,595 |
|
Verrica Pharmaceuticals Inc VRCA
Series C Warrant (right to buy) · derivative
|
2025-11-25 | Buy | 687,690 | ||
|
Verrica Pharmaceuticals Inc VRCA
Common Stock
|
2025-11-25 | Buy | 2,750,762 | $4.24 | 11,663,231 |
|
Verrica Pharmaceuticals Inc VRCA
Common Stock
|
2025-11-25 | Buy | 1,375,380 | $4.24 | 5,831,611 |
|
Verrica Pharmaceuticals Inc VRCA
Series C Warrant (right to buy) · derivative
|
2025-11-25 | Buy | 343,845 | ||
|
Candel Therapeutics Inc CADL
Common Stock
|
2025-06-25 | Grant | 1,070,663 | $4.67 | 4,999,996 |
|
Candel Therapeutics Inc CADL
Stock Option (Right to Buy) · derivative
|
2025-06-17 | Grant | 14,240 | $0.00 | |
|
Liquidia Corp LQDA
Common Stock
|
2025-06-17 | Grant | 18,396 | $0.00 | |
|
Taysha Gene Therapies Inc TSHA
Common Stock
|
2025-05-30 | Buy | 750,000 | $2.75 | 2,062,500 |
|
Candel Therapeutics Inc CADL
Common Stock
|
2024-12-16 | Buy | 500,000 | $6.00 | 3,000,000 |
|
Candel Therapeutics Inc CADL
Common Stock
|
2024-12-16 | Buy | 750,000 | $6.00 | 4,500,000 |
|
Verrica Pharmaceuticals Inc VRCA
Common Stock
|
2024-11-26 | Gift | 450,000 | $0.00 | |
|
Verrica Pharmaceuticals Inc VRCA
Common Stock
|
2024-11-22 | Buy | 18,426,966 | ||
|
Verrica Pharmaceuticals Inc VRCA
Common Stock
|
2024-11-22 | Buy | 4,494,382 | ||
|
Verrica Pharmaceuticals Inc VRCA
Series A Warrants (right to buy) · derivative
|
2024-11-22 | Buy | 2,247,191 | ||
|
Verrica Pharmaceuticals Inc VRCA
Series B Warrants (right to buy) · derivative
|
2024-11-22 | Buy | 2,247,191 | ||
|
Verrica Pharmaceuticals Inc VRCA
Series A Warrants (right to buy) · derivative
|
2024-11-22 | Buy | 9,213,483 | ||
|
Verrica Pharmaceuticals Inc VRCA
Series B Warrants (right to buy) · derivative
|
2024-11-22 | Buy | 9,213,483 | ||
| showing 20 of 164 most recent transactions | |||||